Google
 

Archive for the ‘Blood / Hematology’ Category

Don’t Sit Still And Avoid DVT

Friday, May 16th, 2008

"Desk-bound workers at double DVT risk," reads the headline in The Daily Telegraph. Workers who "sit at a desk for eight hours a day and spend more than three hours without stretching double their risk of developing deep vein thrombosis (DVT)", the newspaper says. The newspaper story is based ...

Better Treatment For Autoimmune Diseases Could Result From Sugar Linkage

Friday, May 16th, 2008

Researchers at the University of New Hampshire Glycomics Center have helped identify a specific carbohydrate structure that confers anti-inflammatory activity to a glycoprotein antibody that could lead to improved treatment of autoimmune diseases like lupus or rheumatoid arthritis. The study, reported in a recent edition of the journal Science, was ...

Dennis Quaid Tells Lawmakers How Drug Mix Up Nearly Killed His Newborn Twins

Thursday, May 15th, 2008

American actor Dennis Quaid went to Capitol Hill today, Wednesday, and told a panel of lawmakers at the House Committee on Oversight and Government Reform about how his baby twins Thomas and Zoe nearly died when they were accidentally given a dose of the blood thinner heparin that was ...

To Encourage Research In Hematology, Promising Medical Trainees Awarded Funding

Thursday, May 15th, 2008

The American Society of Hematology (ASH) is proud to announce the 2008 recipients of its Trainee Research Awards. This year 40 medical students, undergraduates, and residents will each receive $4,000 to conduct research on blood and blood-related diseases through this program, which is designed to encourage the pursuit of research ...

EBMT Has Successful Finish To 34th EBMT Annual Congress, Plans For The Coming Year

Thursday, April 10th, 2008

The 34th Annual Congress of the European Group for Blood and Marrow Transplantation (EBMT) closed its session on the afternoon of 2 April 2008, wrapping up a successful five day Congress with a range of activities, informational sessions, and workshops. This years Congress had a record number of 4,713 ...

Too Much Of A Good Thing: High Levels Of Factor VIIa Cause Problems In Mice

Thursday, April 10th, 2008

Individuals with hemophilia lack either factor VIII or factor IX, proteins crucial for the cascade of events that leads to blood clotting. Although individuals with hemophilia can be treated by intravenous infusion of the factor that they miss, over time, some individuals develop antibodies that prevent the infused factor from ...

Cells On Path To Becoming Mature T Cells More Flexible Than Commonly Thought

Thursday, April 10th, 2008

Contrary to the currently accepted model of T-cell development, researchers at the University of Pennsylvania School of Medicine have found that juvenile cells on their way to becoming mature immune cells can develop into either T cells or other blood-cell types versus only being committed to the T-cell path. The ...

New Data Show Revlimid(R) (lenalidomide) Offers Significant Survival Gainsfor People With Life-limiting Blood Cancer

Thursday, April 10th, 2008

According to data presented today at the 48th Annual Scientific Meeting of the British Society for Haematology (BSH), patients taking Revlimid® (lenalidomide) plus high dose dexamethasone for treatment of multiple myeloma experience a significant survival gain. On average, patients experienced nearly three extra years of life when treated with lenalidomide ...

Gore Revise Study Receives Approval From FDA

Wednesday, April 9th, 2008

FDA approval to proceed with the Gore REVISE (VasculaR AccEss ReVision with Viabahn® EndoproSthesis vs PercutanEous Transluminal Angioplasty) Study was announced today by W. L. Gore & Associates (Gore). The Gore REVISE Study is a randomized, multi-center clinical trial intended to establish efficacy and safety of the GORE VIABAHN® Endoprosthesis ...

Early Diagnosis Of Neurodegenerative Disease On The Horizon

Tuesday, April 8th, 2008

A new blood test that can give an early diagnosis of neurodegenerative disease and distinguish between Parkinson's and Alzheimer's disease could be launched this summer, reports Marina Murphy in SCI's Chemistry & Industry magazine.Manufacturer, Oklahoma-based proteomics company, Power3 Medical Products, said it plans to sell the test, NuroPro, which would ...

Rep. Farr Requests That Policy Barring MSM From Donating Blood Be Re-Evaluated

Monday, April 7th, 2008

Rep. Sam Farr (D-Calif.) on Wednesday requested that the fiscal year 2009 agriculture spending bill include language to require FDA to re-evaluate its policy preventing men who have sex with men from donating blood, Farr spokesperson Tom Mentzer said, CQ Today reports (Sternstein, CQ Today, 4/2). According to the FDA ...

Breakthrough Research In Multiple Myeloma Treatment Flows From IMBCR, The Sole Independent Myelema Research Institute

Saturday, April 5th, 2008

The Institute for Myeloma and Bone Cancer Research (IMBCR), established in 2004 as a 501 c (3) non-profit organization, is headquartered in West Hollywood, California. IMBCR is the only independent non-profit cancer research institute working to find improved treatment, and ultimately a cure for multiple myeloma, a cancer of the ...

Thai Red Cross To Adopt New Policy Banning Blood Donations From MSM

Saturday, April 5th, 2008

The Thai Red Cross Society plans to adopt a policy that bans blood donations from men who have sex with men, the Bangkok Post reports. TRCS said it recently discovered large amounts of unused donated blood that tested positive for HIV. In-depth interviews and preliminary tests found that most ...

Educational Bus Tour To Tell Patients How To Simply And Safely Check Blood Coagulation Levels From Home, UK

Friday, April 4th, 2008

There are more than a million people in the UK on long-term warfarini and this number is set to increase by 10% year-on-year, due to the ageing populationii.Roche Diagnostics, a pioneer in the development of monitoring systems for anticoagulation, supported by the patient group AntiCoagulation Europe (ACE), is conducting an ...

Study Supports New Test To Target Pregnancy Blood Disorder

Friday, April 4th, 2008

According to a study published on bmj.com,researchers have developed a new test that can identify whether amother and her baby have different blood types. Kristin Finning(International Blood Group Reference Laboratory, NHS) and colleaguesmaintain that the test is accurate, feasible, and couldsignificantly reduce unnecessary treatment.If a mother's blood type is Rhesus ...